↓ Skip to main content

Dove Medical Press

Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown

Overview of attention for article published in Eye and Brain, June 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
41 Mendeley
Title
Visual consequences of medications for multiple sclerosis: the good, the bad, the ugly, and the unknown
Published in
Eye and Brain, June 2017
DOI 10.2147/eb.s140481
Pubmed ID
Authors

Heather E Moss

Abstract

Multiple sclerosis (MS) is associated with vision changes both due to MS effects on visual pathways and due to medication effects on the visual pathways. Distinguishing the causes of vision change are critical to appropriate diagnosis and management. The incidence, presentation, and treatment of fingolimod-associated macular edema, alemtuzumab-associated thyroid orbitopathy, and progressive multifocal leukoencephalopathy in MS patients are reviewed. Evidence for beneficial effects of acute, chronic, and symptomatic MS medications on vision is presented.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 17%
Student > Doctoral Student 7 17%
Student > Bachelor 3 7%
Student > Ph. D. Student 3 7%
Other 2 5%
Other 6 15%
Unknown 13 32%
Readers by discipline Count As %
Medicine and Dentistry 15 37%
Neuroscience 3 7%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 1 2%
Psychology 1 2%
Other 3 7%
Unknown 16 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2017.
All research outputs
#16,305,401
of 25,748,735 outputs
Outputs from Eye and Brain
#1
of 1 outputs
Outputs of similar age
#189,721
of 331,548 outputs
Outputs of similar age from Eye and Brain
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 1.5. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,548 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them